title: Adoptive T cell transfer of autoimmune nonobese diabetic mouse diabetes does not require recruitment of host B lymphocytes.
abstract: The autoimmune nonobese diabetic mouse, a model of human juvenile type I diabetes mellitus, exhibits features of both B and T cell autoreactivity against insulin-producing cells. Using the neonatal cell transfer model of the disease, which we have described previously, we have shown that B cell suppression of newborn recipients by anti-mu treatment did not affect the transfer of diabetes by means of T cells. B cell-depleted, purified T cells from diabetic adults were injected into newborns treated with either IR-52, a control rat myeloma protein, or LOMM.9, a rat anti-mouse mu-chain mAb. Both groups developed diabetes over a similar time scale. Although the pancreases in both groups showed massive infiltration by T lymphocytes, B lymphocytes, presumably recruited in the host, were present in the IR-52-treated group, whereas they were absent in the LOMM.9-treated group. Anti-mu-treated diabetic animals showed substantial B cell suppression in vivo and in vitro when compared with IR-52-treated controls. These results suggest that B cell autoreactivity is a secondary phenomenon that is unimportant during the effector phase of diabetes in nonobese diabetic mice.
authors.affiliation: INSERM U 25, Hôpital Necker, Paris, France.
authors.forename: A
authors.initials: A
authors.lastname: Bendelac
authors.forename: C
authors.initials: C
authors.lastname: Boitard
authors.forename: P
authors.initials: P
authors.lastname: Bedossa
authors.forename: H
authors.initials: H
authors.lastname: Bazin
authors.forename: J F
authors.initials: JF
authors.lastname: Bach
authors.forename: C
authors.initials: C
authors.lastname: Carnaud
mesh_terms: D000818:Animals; D000888:Antibodies, Anti-Idiotypic / Q000008:administration & dosage; D000911:Antibodies, Monoclonal / Q000008:administration & dosage; D001327:Autoimmune Diseases / Q000209:etiology / Q000276:immunology* / Q000473:pathology; D001402:B-Lymphocytes / Q000276:immunology*; D003921:Diabetes Mellitus, Experimental / Q000209:etiology / Q000276:immunology* / Q000473:pathology; D005260:Female; D007108:Immune Tolerance; D007116:Immunization, Passive; D007075:Immunoglobulin M / Q000008:administration & dosage / Q000276:immunology; D008297:Male; D051379:Mice; D008815:Mice, Inbred Strains; D009765:Obesity / Q000276:immunology
chemical_list: D000888:Antibodies, Anti-Idiotypic; D000911:Antibodies, Monoclonal; D007075:Immunoglobulin M; C044203:anti-IgM